NDC 51672-1354 - Mupirocin
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 51672-1354
- Package NDCs from labels
- 51672-1354-5, 51672-1354-1, 51672-1354-0, 51672-1354-2
- Manufacturer
- Sun Pharmaceutical Industries, Inc. | Sun Pharma Canada Inc. | Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd | Teva Pharmaceutical Works Private Limited Company | Taro Pharmaceutical Industries Ltd.
- Effective date
- 2023-09-27
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Mupirocin Ointment USP, 2% | Sun Pharmaceutical Industries, Inc. | Sun Pharma Canada Inc. | Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd | Teva Pharmaceutical Works Private Limited Company | Taro Pharmaceutical Industries Ltd. | 2023-09-27 | PRESCRIPTION ANIMAL DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 51672-1354-0 | Mupirocin | 22 g in 1 TUBE | OINTMENT | 22 | 6 | |
| 51672-1354-0 | Mupirocin | 1 in 1 CARTON | OINTMENT | 1 | 6 | |
| 51672-1354-1 | Mupirocin | 15 g in 1 TUBE | OINTMENT | 15 | 6 | |
| 51672-1354-1 | Mupirocin | 1 in 1 CARTON | OINTMENT | 1 | 6 | |
| 51672-1354-2 | Mupirocin | 1 in 1 CARTON | OINTMENT | 1 | 6 | |
| 51672-1354-2 | Mupirocin | 30 g in 1 TUBE | OINTMENT | 30 | 6 | |
| 51672-1354-5 | Mupirocin | 5 g in 1 TUBE | OINTMENT | 5 | 6 | |
| 51672-1354-5 | Mupirocin | 1 in 1 CARTON | OINTMENT | 1 | 6 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 51672-1354 | MUPIROCIN OINTMENT [TARO PHARMACEUTICALS U.S.A., INC.] | 5 | 8 package rows | 20230928_86248181-cdd7-4eaf-8b1a-ef5c1b301d06.zip |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| Mupirocin | ACTIVE INGREDIENT | D0GX863OA5 | MUPIROCIN OINTMENT [TARO PHARMACEUTICALS U.S.A., INC.] | 1 | |
| Mupirocin | ACTIVE MOIETY | D0GX863OA5 | MUPIROCIN OINTMENT [TARO PHARMACEUTICALS U.S.A., INC.] | 1 | |
| polyethylene glycol 3350 | INACTIVE INGREDIENT | G2M7P15E5P | MUPIROCIN OINTMENT [TARO PHARMACEUTICALS U.S.A., INC.] | 1 | |
| polyethylene glycol 400 | INACTIVE INGREDIENT | B697894SGQ | MUPIROCIN OINTMENT [TARO PHARMACEUTICALS U.S.A., INC.] | 1 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| GAVILAX | POLYETHYLENE GLYCOL 3350 | Preferred Pharmaceuticals, Inc. | 21654def-5ae0-422d-961b-1fe2456af00a | 2026-05-04 | Warnings | G2M7P15E5P |
| GoodSense Eye Drops Advanced Relief Moisturizer | DEXTRAN, POLYETHYLENE GLYCOL 400, POVIDONE, TETRAHYDROZOLINE HCL | Preferred PHarmaceuticals Inc. | 011473a8-26d5-4661-b3c0-745f9b6aa1d8 | 2026-04-29 | Warnings | B697894SGQ |
| POLYETHYLENE GLYCOL 3350 | POLYETHYLENE GLYCOL 3350 | CARDINAL HEALTH 110, LLC. DBA LEADER | 04cc4f2e-1725-4710-8cfb-73a6bdf52e4f | 2026-04-23 | Warnings | G2M7P15E5P |
| Polyethylene Glycol 3350 | POLYETHYLENE GLYCOL 3350 | Aurobindo Pharma Limited | b51f2223-8266-4d6c-bf32-58e53e73b54d | 2026-04-23 | Warnings | G2M7P15E5P |
| COMFORTLAX | POLYETHYLENE GLYCOL 3350 | Family Dollar Stores, LLC | 02a44a41-0039-f6ec-e063-6394a90ae6f1 | 2026-04-23 | Warnings | G2M7P15E5P |
| Polyethylene Glycol 3350 | POLYETHYLENE GLYCOL 3350 | Aurohealth LLC | d3c77f3f-57aa-4e2d-88aa-731cbb22af70 | 2026-04-23 | Warnings | G2M7P15E5P |
| PEG 3350 and Electrolytes | POLYETHYLENE GLYCOL 3350, SODIUM SULFATE ANHYDROUS, SODIUM BICARBONATE, SODIUM CHLORIDE, POTASSIUM CHLORIDE | Wilshire Pharmaceuticals, Inc. | b251752d-7750-482a-9364-0acf4ad47cc8 | 2026-04-16 | Warnings, Adverse reactions | G2M7P15E5P |
| GoLYTELY | POLYETHYLENE GLYCOL 3350, SODIUM SULFATE ANHYDROUS, SODIUM BICARBONATE, SODIUM CHLORIDE, POTASSIUM CHLORIDE | Azurity Pharmaceuticals, Inc. | 7609ecf7-0ce0-4fbb-9c27-30987f689575 | 2026-04-15 | Warnings, Adverse reactions | G2M7P15E5P |
| TRILYTE | POLYETHYLENE GLYOCOL 3350, SODIUM CHLORIDE, SODIUM BICARBONATE AND POTASSIUM CHLORIDE | Aurobindo Pharma Limited | 79f5e596-8d51-4227-afcc-f5e341150957 | 2026-04-15 | Warnings, Adverse reactions | G2M7P15E5P |
| PEG 3350, sodium chloride, sodium bicarbonate and potassium chloride | POLYETHYLENE GLYCOL 3350, SODIUM CHLORIDE, SODIUM BICARBONATE, POTASSIUM CHLORIDE | Wilshire Pharmaceuticals, Inc. | 4e442a72-b13b-4869-8a1d-59356095b091 | 2026-04-14 | Warnings, Adverse reactions | G2M7P15E5P |
| Retaine Ultra PF | POLYETHYLENE GLYCOL | OCuSOFT LLC | a5aaaf06-772d-44d3-8601-f978ddc48ad7 | 2026-04-13 | Warnings | B697894SGQ |
| clear lax | POLYETHYLENE GLYCOL 3350 | Meijer Distribution Inc | 6464f12c-0883-46c5-943b-a84fe235588e | 2026-04-13 | Warnings | G2M7P15E5P |
| equate clear lax | POLYETHYLENE GLYCOL 3350 | Wal-Mart Stores Inc | 56a507f3-0cd1-4f02-9dfd-de297ba4bc1f | 2026-03-27 | Warnings | G2M7P15E5P |
| Crocodile Tears Lubricant Eye Drops | GLYCERIN, HYPROMELLOSE, POLYETHYLENE GLYCOL 400 | Crocodile Tears LLC | 4df29336-ea0c-0484-e063-6294a90a685a | 2026-03-26 | Warnings | B697894SGQ |
| Artificial Tears Lubricant Eye Drops | GLYCERIN, HYPROMELLOSE, POLYETHYLENE GLYCOL 400 | KC Pharmaceuticals, Inc | 4de5c844-85ca-ff9f-e063-6394a90ac12c | 2026-03-25 | Warnings | B697894SGQ |
| MUPIROCIN | MUPIROCIN | DIRECT RX | f88eea1a-2ba1-48bf-96c8-d96d18752aaa | 2026-03-20 | Warnings, Adverse reactions | 106346 D0GX863OA5 |
| BLINK TRIPLE CARE | POLYETHYLENE GLYCOL 400 | Bausch & Lomb Incorporated | a2b34eb0-001b-4f42-a8cc-c2a0150fafcc | 2026-03-20 | Warnings | B697894SGQ |
| Mupirocin | MUPIROCIN | PAI Holdings, LLC dba PAI Pharma | a822d44d-c651-406c-a2b9-aa8fbe8f89ce | 2026-03-17 | Warnings, Adverse reactions | 106346 D0GX863OA5 |
| Leader Ultra Lubricating Eye Drops | POLYETHYLENE GLYCOL 400, PROPYLENE GLYCOL | Cardinal Health | d7f011a2-05ba-47c3-9519-d31602e105c7 | 2026-03-12 | Warnings | B697894SGQ |
| Leader Advanced Relief Eye Drops | DEXTRAN 70, POLYETHYLENE GLYCOL 400, POVIDONE, TETRAHYDROZOLINE HCL | Cardinal Health | 5c5d6c13-9b51-48f0-8627-b60b0f707fd3 | 2026-03-12 | Warnings | B697894SGQ |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.